Konferenzen  >  Biowissenschaften  >  Biotechnologie

CHI

Commercializing breakthrough immune-oncology therapeutics is becoming increasingly challenging due to funding limitations, high cost and attrition rates in the clinic, regulatory uncertainties, persistent therapeutic safety and efficacy concerns, and a general lack of understanding of basic biology guiding research in this space. As we develop the 2025 conference program, we are struck by the fact that, despite these challenges, there remains a strong desire to continue to find effective therapeutics for solid tumors. The 13th Annual Immuno-Oncology Summit showcases successes in preclinical and clinical studies grounded in a deep understanding of biology. Coverage spans solid tumor innovations, including bi/multispecific antibodies, antibody-drug conjugates (ADCs), allogenic and in vivo CAR-Ts, TILs, TCRs, Tregs, multiple cell therapies working together, the tumor microenvironment, innate immunity, gamma delta T cells, NK cells, organoid modeling, data science, and machine learning. The program also explores autoimmunity as a critical and complementary area of focus.

Tel.: [781.972.5400];     Email: chi@healthtech.com

Onkologie,    Immunologie und Allergie

CHI

Join a global community of thought leaders and innovators shaping the future of bioprocessing. Dive into cutting-edge research, share insights with industry experts, and tackle the challenges of bioprocess R&D, scale-up, quality, and analytics.

Tel.: [781.972.5400];     Email: chi@healthtech.com

Chemical engineering, biotechnology and bioprocessing are the key to providing innovative solutions for food supply, mobility, energy, health and well-being while striving for a sustainable economy. At ECCE 15 & ECAB 8, scientists from industry, universities and research institutions from Europe and beyond will meet in Lisbon to discuss the latest research and industrial applications in all fields of chemistry, process engineering, biotechnology and related fields. This year’s conference will be held in conjunction with the 3rd CIBIQ - Iberoamerican Congress on Chemical Engineering.

Informa

The premier Asia-Pacific biopharma conference for global cross-border partnerships

Tel.: [801 891 9874];     Email: cchang@ebdgroup.com

The third edition of Asia Bio Partnering Forum will continue to build on its strong start and the unrivalled success of its sister event ChinaBio® Partnering Forum. The event will take place in-person from September 9–10, 2025, in Singapore, and will convene biotech and pharma leaders from around the world with hundreds of emerging innovators across the Asia Pacific region to advance dealmaking in Asia. The event will feature a blend of live and on-demand program sessions, company presentations, table-top exhibits, company showcases, partnering meetings and networking sessions. In keeping with EBD Group’s commitment to facilitate strategic connections that drive dealmaking, the event will also feature two days of digital partnering from September 16–17, 2025, hosted on partneringONE™. Digital partnering enables young biotech companies to gain valuable visibility and the opportunity to forge partnerships that move their research to the next level.

CHI

In its 23rd year Discovery on Target is the premier event highlighting “hot” drug targets and emerging modalities, technologies and strategies for pursuing those targets. The numerous conferences, symposia, courses and training seminars offer key insights for the successful discovery and development of novel therapeutics, from small molecules to biologics to chimeras and conjugates. The 4 day event covers innovations in target identification and lead generation, which includes cancer therapies, protein degradation, induced proximity, AI/machine learning, membrane proteins, translational models, synthetic biology and other relevant topics. New this year is an increased coverage of GLP-1, MASH and obesity, ADCs and bispecifics and on small molecules targeting DNA.

Tel.: [781.972.5400];     Email: chi@healthtech.com

Onkologie,    Pharmakologie und Arzneimittelentwicklung

Faculty of Biology, University of Plovdiv

The Faculty of Biology at the University of Plovdiv “Paisii Hilendarski” and the Institute of Molecular Biology at the Bulgarian Academy of Sciences are thrilled to announce the 6th Balkan Conference on BioSciences (balkan.bio 2025)! This exciting event will take place on October 30–31, 2025, and promises to build on the remarkable success of its five previous editions in Plovdiv (2005, 2010, 2014, 2017, and 2020). With its tradition of fostering vibrant discussions and groundbreaking research, this year’s conference is set to provide an inspiring and collaborative atmosphere, bringing together top minds to explore the latest in biological sciences. Don’t miss the chance to be part of this dynamic gathering!

Conference office;     Tel.: [+35932261566];     Email: balkanbio@uni-plovdiv.bg

Genetics, Cell Biology, Molecular Biology, Bioinformatics, Biodiversity, Conservation, Microbiology, Biotechnology, Biomedical Sciences

Biologie,    Molekularbiologie